Financhill
Buy
55

GSBD Quote, Financials, Valuation and Earnings

Last price:
$12.76
Seasonality move :
-5.04%
Day range:
$12.76 - $12.85
52-week range:
$12.65 - $15.94
Dividend yield:
14.11%
P/E ratio:
18.23x
P/S ratio:
15.83x
P/B ratio:
0.94x
Volume:
1.3M
Avg. volume:
1M
1-year change:
-17.04%
Market cap:
$1.5B
Revenue:
$208M
EPS (TTM):
$0.70

Analysts' Opinion

  • Consensus Rating
    Goldman Sachs BDC has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Downside
    According to analysts' consensus price target of --, Goldman Sachs BDC has an estimated downside of -0.73% from its current price of $12.76.
  • Price Target Upside
    According to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $12.76.

Fair Value

  • According to the consensus of 0 analysts, Goldman Sachs BDC has -0.73% downside to fair value with a price target of -- per share.

GSBD vs. S&P 500

  • Over the past 5 trading days, Goldman Sachs BDC has underperformed the S&P 500 by -0.91% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Goldman Sachs BDC does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Goldman Sachs BDC revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Goldman Sachs BDC reported revenues of $41.4M.

Earnings Growth

  • Goldman Sachs BDC earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Goldman Sachs BDC reported earnings per share of $0.32.
Enterprise value:
3.3B
EV / Invested capital:
0.96x
Price / LTM sales:
15.83x
EV / EBIT:
17.00x
EV / Revenue:
36.58x
PEG ratio (5yr expected):
13.78x
EV / Free cash flow:
46.09x
Price / Operating cash flow:
19.95x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
2.13%
Net Income Margin (TTM):
83.48%
Return On Equity:
4.73%
Return On Invested Capital:
2.18%
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Income Statement
Revenue $82.5M $161.8M $90.9M $55.5M $41.4M
Gross Profit -- -- -- -- --
Operating Income -- -- -- -- --
EBITDA -- -- -- -- --
Diluted EPS $0.88 $1.38 $0.70 $0.47 $0.32
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Balance Sheet
Current Assets $27.6M $193.7M $77.1M $107.4M $85.7M
Total Assets $1.6B $3.3B $3.7B $3.6B $3.5B
Current Liabilities $26.9M $72.1M $62.2M $70.6M $69.8M
Total Liabilities $943M $1.7B $2.2B $2B $2B
Total Equity $626.4M $1.6B $1.5B $1.6B $1.6B
Total Debt $911.7M $1.6B $2.1B $1.9B $1.9B
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Cash Flow Statement
Cash Flow Operations -$436.7M $355M $72.1M $159.7M $104.1M
Cash From Investing -- -- -- -- --
Cash From Financing $297.8M -$311.2M -$95.9M -$125.5M -$112.8M
Free Cash Flow -$436.7M $355M $72.1M $159.7M $104.1M
GSBD
Sector
Market Cap
$1.5B
$700.3M
Price % of 52-Week High
80.05%
88.31%
Dividend Yield
14.11%
2.2%
Shareholder Yield
7.19%
3.87%
1-Year Price Total Return
-17.04%
7.75%
Beta (5-Year)
1.057
0.737
Dividend yield:
14.11%
Annualized payout:
$1.80
Payout ratio:
258.51%
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Sell
Level $12.77
200-day SMA
Sell
Level $14.42
Bollinger Bands (100)
Sell
Level 12.97 - 14.09
Chaikin Money Flow
Sell
Level -31M
20-day SMA
Sell
Level $12.88
Relative Strength Index (RSI14)
Sell
Level 43.71
ADX Line
Buy
Level 13.78
Williams %R
Neutral
Level -78.8217
50-day SMA
Sell
Level $13.06
MACD (12, 26)
Sell
Level -0.08
25-day Aroon Oscillator
Sell
Level -64
On Balance Volume
Sell
Level -15.6M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (0.7662)
Sell
CA Score (Annual)
Level (-0.339)
--
Beneish M-Score (Annual)
Level (--)
Sell
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-0.1956)
--
Piotroski F Score (Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (7)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Goldman Sachs BDC Inc is a non-diversified, closed-end management investment company that elected to be regulated as a business development company focused on lending to middle-market companies. The investment objective is to generate current income and, to a lesser extent, capital appreciation primarily through direct originations of secured debt, including the first lien, unitranche and second lien debt, and unsecured debt. It invests primarily in U.S. middle-market companies such as banks and the public debt markets. The company's origination strategy focuses on leading the negotiation and structuring of the loans or securities in which it invests and holding the investments in its portfolio to maturity. It generates majority revenue in the form of interest income and dividend income.

Stock Forecast FAQ

In the current month, GSBD has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The GSBD average analyst price target in the past 3 months is --.

  • Where Will Goldman Sachs BDC Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Goldman Sachs BDC share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About Goldman Sachs BDC?

    Analysts are divided on their view about Goldman Sachs BDC share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Goldman Sachs BDC is a Sell and believe this share price will rise from its current level to --.

  • What Is Goldman Sachs BDC's Price Target?

    The price target for Goldman Sachs BDC over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is GSBD A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Goldman Sachs BDC is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of GSBD?

    You can purchase shares of Goldman Sachs BDC via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Goldman Sachs BDC shares.

  • What Is The Goldman Sachs BDC Share Price Today?

    Goldman Sachs BDC was last trading at $12.76 per share. This represents the most recent stock quote for Goldman Sachs BDC. Yesterday, Goldman Sachs BDC closed at $12.76 per share.

  • How To Buy Goldman Sachs BDC Stock Online?

    In order to purchase Goldman Sachs BDC stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Will Airbnb Stock Go?
How High Will Airbnb Stock Go?

Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…

Why Is SoundHound AI Stock Up So Much?
Why Is SoundHound AI Stock Up So Much?

Like many companies improving AI technologies and exploring ways to…

Is The Santa Claus Rally The Gift That Keeps Giving?
Is The Santa Claus Rally The Gift That Keeps Giving?

Remember the horror of 2008 when the Great Recession hit…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 43x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
57
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Buy
64
ARQQ alert for Dec 27

Arqit Quantum [ARQQ] is up 49.85% over the past day.

Buy
64
QMCO alert for Dec 27

Quantum [QMCO] is up 49.62% over the past day.

Buy
65
ALGS alert for Dec 27

Aligos Therapeutics [ALGS] is up 10.88% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock